The Harbor Health editorial team includes physicians, pharmacists, and health writers dedicated to providing accurate, evidence-based information about weight management and GLP-1 medications.
The two leading GLP-1 weight loss medications compared at the molecule level. Mechanism, clinical-trial efficacy, side effects, cost, cardiovascular outcomes, and the framework Harbor's clinical team uses to choose between them.
Zepbound is brand-name tirzepatide for weight loss. Compounded tirzepatide is the same molecule prepared differently. The choice in 2026 comes down to cost, insurance coverage, and tolerance for the trade-offs of each path. Written by Harbor's medical team.
Two FDA-approved weight loss injections from competing manufacturers, compared on every metric that matters in 2026. Mechanism, trial-grade efficacy, side effects, real cost, and how to choose, by Harbor's medical team.
Mounjaro and compounded tirzepatide contain the exact same active ingredient. The differences are FDA label, manufacturer, cost, and regulatory framework. Here's the honest breakdown from Harbor's medical team.
A side-by-side clinical comparison of tirzepatide and Ozempic for weight loss. Mechanism, trial-grade efficacy, side effects, real cost in 2026, and exactly how to switch, by Harbor's medical team.
For the estimated 37 million Americans living with type 2 diabetes, the relationship between blood sugar management and weight loss has always been frustratingly circular: excess weight drives insulin resistance, insulin resistance makes weight loss harder, and many diabetes medications actually cause weight gain as a side effect.
Everything you need to know about GLP-1 receptor agonists — how they work, what to expect, and whether they might be right for your weight loss journey.
The rise of GLP-1 weight loss treatments has revolutionized obesity care, offering a new level of effectiveness through once-weekly injections.
